Iaml Competitors

The AI Collective is a global non-profit building the human layer for the AI age. We unite 200,000+ leaders, builders, and stakeholders across 100+ forums worldwide to democratize the frontier, build trust, and coordinate how society navigates the rapid acceleration of technological progress.

We’re East Londoners and proud. With over 30 years’ experience developing commercial and residential property across London, we pride ourselves on our high-quality and design-led schemes. Founded by Hackney born Henry Smith in 1995, Aitch Group has earned a reputation as a leading property developer in London. Built upon strong values, we’re committed to uncovering the potential for communities to flourish and building a future for people to thrive. We’re here to do a job and to do it well, that’s why we employ the most exceptional talent in the industry. We encourage an entrepreneurial culture at Aitch Group and support our teams’ development to continually pioneer. Our integrated team work together throughout the regeneration process, managing the acquisition, funding, planning, design, construction and marketing of each project. Reliable, flexible and solutions focused, we develop stylish and innovative spaces for communities to live and work.

GrapheneAI is Asia’s fastest growing Decision science company. Founded in 2014, our fundamental mission is to disrupt traditional market research using artificial intelligence. With a focus on Pharma and Healthcare, FMCG & Banking, and a leadership team made up of technology, domain and business experts, GrapheneAI brings to its engagements a practitioner’s perspective and depth of industry insight. With offices in India, Singapore and the US, GrapheneAI has delivered solutions across the globe. Graphene uses AI-empowered market research to provide unbiased insights faster and cheaper. Built by domain experts in Pharma and Healthcare it supports 5 of the top 10 global pharma companies across 26 countries. GrapheneAI helps companies reduce time to market and significantly enhance engagement with key stakeholders including consumers, doctors, patients and caregivers. From awareness and sentiment, to perception and behavior, it provides actionable insights that helps companies address the challenges in pharma & healthcare (diagnosis, treatment and infrastructure) and FMCG (brand equity, campaign effectiveness) so that companies can better support patients/consumers. GrapheneAI provides insights in 55 different languages using a wide variety of sources that are relevant to respective domains (Pharma & Healthcare and FMCG).